Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Tafenoquine in Healthy Volunteers
NCT03320174Phase 2Completed
- Sponsor
- 60 Degrees Pharmaceuticals
- Start
- Oct 2017
- Primary completion
- Jul 2021
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tafenoquine in malaria, sponsored by 60 Degrees Pharmaceuticals. Started Oct 2017; status: completed.
02
Drugs
tafenoquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT03320174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03320174.